Performance of the intracerebroventricularly injected streptozotocin Alzheimer’s disease model in a translationally relevant, aged and experienced rat population

• Published in: Scientific reports Vol. 12; no. 1; pp. 20247 - 13
• Main Authors: Gáspár, Attila, Hutka, Barbara, Ernyey, Aliz Judit, Tajti, Brigitta Tekla, Varga, Bence Tamás, Zádori, Zoltán Sándor, Gyertyán, István
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 24-11-2022; Nature Publishing Group; Nature Portfolio
• Subjects: 631/378/1689; 631/378/1689/1283; Activity patterns; Age; Alzheimer Disease - chemically induced; Alzheimer Disease - drug therapy; Alzheimer's disease; Animal cognition; Animal populations; Animals; Cognitive ability; Cooperation; Cooperativity; Disease Models, Animal; Fear conditioning; Food availability; Hippocampus; Humanities and Social Sciences; Impulsive behavior; Jumping; Memory; multidisciplinary; Neurodegenerative diseases; Pattern recognition; Rats; Rats, Long-Evans; Rats, Wistar; Reaction time task; Science; Science (multidisciplinary); Social interactions; Spatial discrimination learning; Streptozocin; Streptozocin - pharmacology; Tau protein; Visual discrimination; β-Amyloid
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-24292-5

The intracerebroventricularly (icv) injected streptozotocin (STZ) induced brain state is a widely used model of sporadic Alzheimer-disease (AD). However, data have been generated in young, naive albino rats. We postulate that the translationally most relevant animal population of an AD model should be that of aged rats with substantial learning history. The objective of the study was thus to probe the model in old rats with knowledge in various cognitive domains. Long-Evans rats of 23 and 10 months age with acquired knowledge in five-choice serial reaction time task (5-CSRTT), a cooperation task, Morris water-maze (MWM) and “pot-jumping” exercise were treated with 3 × 1.5 mg/kg icv. STZ and their performance were followed for 3 months in the above and additional behavioral assays. Both STZ-treated age groups showed significant impairment in the MWM (spatial learning) and novel object recognition test (recognition memory) but not in passive avoidance and fear conditioning paradigms (fear memory). In young STZ treated rats, significant differences were also found in the 5CSRTT (attention) and pot jumping test (procedural learning) while in old rats a significant increase in hippocampal phospho-tau/tau protein ratio was observed. No significant difference was found in the cooperation (social cognition) and pairwise discrimination (visual memory) assays and hippocampal β-amyloid levels. STZ treated old animals showed impulsivity-like behavior in several tests. Our results partly coincide with partly deviate from those published on young, albino, unexperienced rats. Beside the age, strain and experience level of the animals differences can also be attributed to the increased dose of STZ, and the applied food restriction regime. The observed cognitive and non-cognitive activity pattern of icv. STZ in aged experienced rats call for more extensive studies with the STZ model to further strengthen and specify its translational validity.